Total Payments
$7,293
2024 Payments
$1,520
Companies
39
Transactions
445
Medicare Patients
7,727
Medicare Billing
$348,938
Payment Breakdown by Category
Food & Beverage$7,274 (99.7%)
Education$19.46 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,274 | 442 | 99.7% |
| Education | $19.46 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,261 | 80 | $0 (2024) |
| ABBVIE INC. | $724.78 | 41 | $0 (2024) |
| PFIZER INC. | $619.12 | 42 | $0 (2024) |
| Lilly USA, LLC | $506.37 | 35 | $0 (2024) |
| Amgen Inc. | $485.69 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $384.66 | 28 | $0 (2024) |
| GlaxoSmithKline, LLC. | $382.42 | 25 | $0 (2024) |
| Astellas Pharma US Inc | $363.67 | 20 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $345.81 | 20 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $319.36 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,520 | 85 | Novo Nordisk Inc ($365.43) |
| 2023 | $1,618 | 99 | Novo Nordisk Inc ($345.17) |
| 2022 | $639.33 | 35 | ABBVIE INC. ($106.56) |
| 2021 | $13.26 | 1 | AstraZeneca Pharmaceuticals LP ($13.26) |
| 2020 | $181.43 | 12 | PFIZER INC. ($42.25) |
| 2019 | $1,321 | 82 | Amgen Inc. ($161.77) |
| 2018 | $1,311 | 85 | Novo Nordisk Inc ($216.43) |
| 2017 | $689.34 | 46 | Novo Nordisk Inc ($138.43) |
All Payment Transactions
445 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Obesity | ||||||
| 09/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: PAIN | ||||||
| 09/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.34 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: UROLOGY | ||||||
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Bone Health | ||||||
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: DIABETES | ||||||
| 08/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $32.46 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: UROLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Biological | ||||||
| 07/24/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: Obesity | ||||||
| 07/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Bone Health | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 1,888 | 2,520 | $217,685 | $94,702 |
| 2022 | 31 | 1,937 | 2,471 | $209,276 | $88,325 |
| 2021 | 32 | 2,043 | 2,773 | $217,324 | $90,951 |
| 2020 | 30 | 1,859 | 2,371 | $203,883 | $74,960 |
Total Patients
7,727
Total Services
10,135
Medicare Billing
$348,938
Procedure Codes
124
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 243 | 452 | $71,290 | $35,731 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 189 | 330 | $35,445 | $18,397 | 51.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 95 | 95 | $15,930 | $11,386 | 71.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 56 | 57 | $5,625 | $3,939 | 70.0% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 11 | 11 | $3,795 | $2,781 | 73.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 197 | 321 | $4,815 | $2,688 | 55.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $6,780 | $2,355 | 34.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 83 | 110 | $7,700 | $1,794 | 23.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 58 | 59 | $2,360 | $1,674 | 71.0% |
| 77067 | Screening mammography | Office | 2023 | 20 | 20 | $6,400 | $1,648 | 25.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 119 | 127 | $8,890 | $1,640 | 18.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 141 | 153 | $9,180 | $1,563 | 17.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 136 | 150 | $6,000 | $1,126 | 18.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 75 | 115 | $5,175 | $1,085 | 21.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 32 | $2,080 | $1,080 | 51.9% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 72 | 99 | $4,950 | $820.71 | 16.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 22 | 22 | $2,750 | $758.20 | 27.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 18 | 21 | $2,310 | $609.21 | 26.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 11 | 12 | $1,920 | $603.36 | 31.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $700.00 | $577.40 | 82.5% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 20 | 20 | $1,400 | $428.20 | 30.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 22 | 22 | $1,430 | $325.16 | 22.7% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 31 | 40 | $1,600 | $247.26 | 15.5% |
| 82746 | Folic acid level, serum | Office | 2023 | 17 | 17 | $1,275 | $244.97 | 19.2% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 26 | 29 | $1,305 | $229.39 | 17.6% |
About Dr. Christopher Inhulsen, MD
Dr. Christopher Inhulsen, MD is a Internal Medicine healthcare provider based in Cartersville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2011. The National Provider Identifier (NPI) number assigned to this provider is 1124324967.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Inhulsen, MD has received a total of $7,293 in payments from pharmaceutical and medical device companies, with $1,520 received in 2024. These payments were reported across 445 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,274).
As a Medicare-enrolled provider, Inhulsen has provided services to 7,727 Medicare beneficiaries, totaling 10,135 services with total Medicare billing of $348,938. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Cartersville, GA
- Active Since 01/26/2011
- Last Updated 05/08/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124324967
Products in Payments
- Ozempic (Drug) $471.33
- VRAYLAR (Drug) $341.28
- JARDIANCE (Drug) $300.18
- FARXIGA (Drug) $295.12
- MOUNJARO (Drug) $260.07
- Victoza (Drug) $246.61
- Wegovy (Drug) $228.97
- TRELEGY ELLIPTA (Drug) $207.67
- Rybelsus (Drug) $207.29
- Dexcom G6 Transmitter (Medical Supply) $191.61
- ENTRESTO (Drug) $188.96
- TOUJEO (Drug) $181.26
- ELIQUIS (Drug) $180.75
- EVENITY (Biological) $177.64
- VESICARE (Drug) $154.86
- NURTEC ODT (Drug) $140.34
- XARELTO (Drug) $138.51
- TRULICITY (Drug) $127.62
- GEMTESA (Drug) $119.91
- Aimovig (Biological) $118.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cartersville
Dr. David Kim, Md, MD
Internal Medicine — Payments: $12,616
Internal Medicine $12,616
Antonio Baute, Md, MD
Internal Medicine — Payments: $12,568
Internal Medicine $12,568
Sreedhar Maddineni, M.d, M.D
Internal Medicine — Payments: $4,706
Internal Medicine $4,706
Dr. Jeffrey Esslinger, M.d, M.D
Internal Medicine — Payments: $4,661
Internal Medicine $4,661
Prasad Rao, M.d, M.D
Internal Medicine — Payments: $3,679
Internal Medicine $3,679
Dr. Willie Gilbert, Do, DO
Internal Medicine — Payments: $1,565
Internal Medicine $1,565